Piramal Pharma Ltd. share price target

Name: Latest research reports of Piramal Pharma Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Piramal Pharma Ltd.
Rating: 5
Author: ICICI Securities Limited

Piramal Pharma Ltd. has an average share price target of 262.67. The consensus estimate represents an upside of 39.92% from the last price of 187.73. View 5 reports from 3 analysts offering long-term price targets for Piramal Pharma Ltd..

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Load latest Google or static link led you to an intermediate page.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
29 Sep 2025	Piramal Pharma	Consensus Share Price Target	187.73	258.67	-	37.79	buy	pdf Detailed Estimates
14 Nov 2022	Piramal Pharma	ICICI Securities Limited	187.73	200.00	139.50 (34.57%)	Pre-Bonus/ Split	Buy	pdf post cache	Broker Report Expect stronger H2 driven by CDMO ICICI Securities Limited Piramal Pharma’s (PPL) Q2FY23 performance was driven by growth across its business segments. Revenue grew 9.0% YoY (+16% QoQ) to Rs17.2bn. pdf Copy Link Share on Share on Share on Share on Alert
10 Nov 2022	Piramal Pharma	Motilal Oswal	187.73	185.00	142.95 (31.33%)	Pre-Bonus/ Split	Buy	pdf post cache	Broker Report Work-in-progress to address challenges in the CDMO segment Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

Near 52W Low of ₹181.73

Piramal Pharma Ltd. share price target

Piramal Pharma Ltd. has an average share price target of 262.67. The consensus estimate represents an upside of 39.92% from the last price of 187.73. View 5 reports from 3 analysts offering long-term price targets for Piramal Pharma Ltd..

Expect stronger H2 driven by CDMO

Work-in-progress to address challenges in the CDMO segment

Advisor Screeners